91
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dravet syndrome is an epilepsy syndrome of infantile onset, frequently caused by SCN1A mutations or deletions. Its prevalence, long-term evolution in adults and neuropathology are not well known. We identified a series of 22 adult patients, including three adult post-mortem cases with Dravet syndrome. For all patients, we reviewed the clinical history, seizure types and frequency, antiepileptic drugs, cognitive, social and functional outcome and results of investigations. A systematic neuropathology study was performed, with post-mortem material from three adult cases with Dravet syndrome, in comparison with controls and a range of relevant paediatric tissue. Twenty-two adults with Dravet syndrome, 10 female, were included, median age 39 years (range 20–66). SCN1A structural variation was found in 60% of the adult Dravet patients tested, including one post-mortem case with DNA extracted from brain tissue. Novel mutations were described for 11 adult patients; one patient had three SCN1A mutations. Features of Dravet syndrome in adulthood include multiple seizure types despite polytherapy, and age-dependent evolution in seizure semiology and electroencephalographic pattern. Fever sensitivity persisted through adulthood in 11 cases. Neurological decline occurred in adulthood with cognitive and motor deterioration. Dysphagia may develop in or after the fourth decade of life, leading to significant morbidity, or death. The correct diagnosis at an older age made an impact at several levels. Treatment changes improved seizure control even after years of drug resistance in all three cases with sufficient follow-up after drug changes were instituted; better control led to significant improvement in cognitive performance and quality of life in adulthood in two cases. There was no histopathological hallmark feature of Dravet syndrome in this series. Strikingly, there was remarkable preservation of neurons and interneurons in the neocortex and hippocampi of Dravet adult post-mortem cases. Our study provides evidence that Dravet syndrome is at least in part an epileptic encephalopathy.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: not found
          • Article: not found

          A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology.

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy.

            (1989)
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy.

              Severe myoclonic epilepsy of infancy (SMEI) is a rare disorder that occurs in isolated patients. The disease is characterized by generalized tonic, clonic, and tonic-clonic seizures that are initially induced by fever and begin during the first year of life. Later, patients also manifest other seizure types, including absence, myoclonic, and simple and complex partial seizures. Psychomotor development stagnates around the second year of life. Missense mutations in the gene that codes for a neuronal voltage-gated sodium-channel alpha-subunit (SCN1A) were identified in families with generalized epilepsy with febrile seizures plus (GEFS+). GEFS+ is a mild type of epilepsy associated with febrile and afebrile seizures. Because both GEFS+ and SMEI involve fever-associated seizures, we screened seven unrelated patients with SMEI for mutations in SCN1A. We identified a mutation in each patient: four had frameshift mutations, one had a nonsense mutation, one had a splice-donor mutation, and one had a missense mutation. All mutations are de novo mutations and were not observed in 184 control chromosomes.
                Bookmark

                Author and article information

                Journal
                Brain
                brainj
                brain
                Brain
                Oxford University Press
                0006-8950
                1460-2156
                October 2011
                29 June 2011
                29 June 2011
                : 134
                : 10
                : 2982-3010
                Affiliations
                1 Department of Clinical and Experimental Epilepsy, UCL Institute of Neurology and National Hospital for Neurology and Neurosurgery, UCL, Queen Square, London WC1N 3BG, UK
                2 National Society for Epilepsy, Chesham Lane, Chalfont St Peter, Bucks SL9 0RJ, UK
                3 Division of Neuropathology, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK
                4 Neurogenetics Unit, National Hospital for Neurology and Neurosurgery, Institute of Neurology, London WC1N 3BG, UK
                5 Paediatric Neurosciences Research Group, Fraser of Allander Neurosciences Unit, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8SJ, UK
                6 Duncan Guthrie Institute of Medical Genetics, Royal Hospital for Sick Children, Yorkhill, Glasgow G3 8SJ, UK
                7 UCL Institute of Child Health, 30 Guilford Street, London WC1N 1EH, UK
                8 Great Ormond Street Hospital for Children NHS Trust, 34 Great Ormond Street London, WC1N 3JH, UK
                9 National Centre for Young People with Epilepsy, St Piers Lane, Lingfield, RH7 6PW, UK
                10 Roald Dahl EEG Department, Littlewood's Neurosciences Unit, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, Merseyside L12 2AP, UK
                11 Epilepsy Research Centre, Department of Medicine (Neurology), University of Melbourne, Victoria 3052, Australia
                12 Department of Paediatrics, Royal Children's Hospital, University of Melbourne, Victoria 3081, Australia
                Author notes
                Correspondence to: Sanjay M. Sisodiya, Department of Clinical and Experimental Epilepsy, National Hospital for Neurology and Neurosurgery, Queen Square, London WC1N 3BG, UK E-mail: s.sisodiya@ 123456ion.ucl.ac.uk
                Article
                awr129
                10.1093/brain/awr129
                3187538
                21719429
                4b476db4-3d5a-4601-9030-b1ec19468d66
                © The Author (2011). Published by Oxford University Press on behalf of the Guarantors of Brain.

                This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 7 November 2010
                : 19 April 2011
                : 19 April 2011
                Page count
                Pages: 29
                Categories
                Original Articles

                Neurosciences
                scn1a,neuropathology,na+ channel,encephalopathy,epilepsy
                Neurosciences
                scn1a, neuropathology, na+ channel, encephalopathy, epilepsy

                Comments

                Comment on this article